These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 6586491)
41. The fate of saccharin impurities: the excretion and metabolism of toluene-2-sulphonamide in man and rat. Renwick AG; Ball LM; Corina DL; Williams RT Xenobiotica; 1978 Aug; 8(8):461-74. PubMed ID: 695690 [TBL] [Abstract][Full Text] [Related]
42. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs. Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117 [TBL] [Abstract][Full Text] [Related]
43. Pharmacokinetics and metabolism of a RAS farnesyl transferase inhibitor in rats and dogs: in vitro-in vivo correlation. Singh R; Chen IW; Jin L; Silva MV; Arison BH; Lin JH; Wong BK Drug Metab Dispos; 2001 Dec; 29(12):1578-87. PubMed ID: 11717177 [TBL] [Abstract][Full Text] [Related]
44. Disposition of cefotaxime in rat, dog and man. Macdonald CM; Fromson JM; McDonald A; Dell D; Chamberlain J; Coombes JD Arzneimittelforschung; 1984; 34(12):1719-23. PubMed ID: 6099125 [TBL] [Abstract][Full Text] [Related]
45. Comparative metabolism of radiolabeled muraglitazar in animals and humans by quantitative and qualitative metabolite profiling. Zhang D; Wang L; Raghavan N; Zhang H; Li W; Cheng PT; Yao M; Zhang L; Zhu M; Bonacorsi S; Yeola S; Mitroka J; Hariharan N; Hosagrahara V; Chandrasena G; Shyu WC; Humphreys WG Drug Metab Dispos; 2007 Jan; 35(1):150-67. PubMed ID: 17062777 [TBL] [Abstract][Full Text] [Related]
46. Metabolism of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate in rats, guinea pigs, dogs and monkeys. Sugiyama M; Ando T; Okuyama Y; Sugimoto T; Choukai S Arzneimittelforschung; 1986 Aug; 36(8):1229-36. PubMed ID: 3778560 [TBL] [Abstract][Full Text] [Related]
47. Species differences in metabolism and pharmacokinetics of a sphingosine-1-phosphate receptor agonist in rats and dogs: formation of a unique glutathione adduct in the rat. Anari MR; Creighton MD; Ngui JS; Tschirret-Guth RA; Teffera Y; Doss GA; Tang W; Yu NX; Ciccotto SL; Hobra DF; Coleman JB; Vincent SH; Evans DC Drug Metab Dispos; 2006 Aug; 34(8):1367-75. PubMed ID: 16698892 [TBL] [Abstract][Full Text] [Related]
48. Biotransformation of carbon-14-labeled muraglitazar in male mice: interspecies difference in metabolic pathways leading to unique metabolites. Li W; Zhang D; Wang L; Zhang H; Cheng PT; Zhang D; Everett DW; Humphreys WG Drug Metab Dispos; 2006 May; 34(5):807-20. PubMed ID: 16467134 [TBL] [Abstract][Full Text] [Related]
49. Biotransformation of cerivastatin in mice, rats, and dogs in vivo. Boberg M; Angerbauer R; Kanhai WK; Karl W; Kern A; Radtke M; Steinke W Drug Metab Dispos; 1998 Jul; 26(7):640-52. PubMed ID: 9660846 [TBL] [Abstract][Full Text] [Related]
50. Metabolic fate of [14C]-ceftizoxime, a parenteral cephalosporin antibiotic, in rats and dogs. Noda K; Suzuki A; Ohta H; Furukawa T; Noguchi H Arzneimittelforschung; 1980; 30(10):1665-9. PubMed ID: 6933993 [TBL] [Abstract][Full Text] [Related]
51. Disposition of remoxipride in different species. Species differences in metabolism. Widman M; Nilsson LB; Bryske B; Lundström J Arzneimittelforschung; 1993 Mar; 43(3):287-97. PubMed ID: 8489555 [TBL] [Abstract][Full Text] [Related]
52. Fate and disposition of bromocriptine in animals and man. II: Absorption, elimination and metabolism. Maurer G; Schreier E; Delaborde S; Nufer R; Shukla AP Eur J Drug Metab Pharmacokinet; 1983; 8(1):51-62. PubMed ID: 6861794 [TBL] [Abstract][Full Text] [Related]
53. [Pharmacokinetics of Morocromen in animals and man (author's transl)]. Dell HD; Jacobi H; Kamp R; Lorenz D Arzneimittelforschung; 1982; 32(5):492-8. PubMed ID: 7201825 [TBL] [Abstract][Full Text] [Related]
54. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats. Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879 [TBL] [Abstract][Full Text] [Related]
55. Metabolism, disposition, excretion, and pharmacokinetics of levormeloxifene, a selective estrogen receptor modulator, in the rat. Mountfield RJ; Kiehr B; John BA Drug Metab Dispos; 2000 May; 28(5):503-13. PubMed ID: 10772628 [TBL] [Abstract][Full Text] [Related]
56. Disposition of a series of tetrahydrocarbazoles. Edelson J; Benziger DP Drug Metab Rev; 1980; 11(2):263-89. PubMed ID: 7011760 [TBL] [Abstract][Full Text] [Related]
57. Pharmacokinetics of terbutaline after parenteral administration. Fagerström PO Eur J Respir Dis Suppl; 1984; 134():101-10. PubMed ID: 6586470 [TBL] [Abstract][Full Text] [Related]
58. Excretion and metabolism of flunarizine in rats and dogs. Meuldermans W; Hendrickx J; Hurkmans R; Swysen E; Woestenborghs R; Lauwers W; Heykants J Arzneimittelforschung; 1983; 33(8):1142-51. PubMed ID: 6685491 [TBL] [Abstract][Full Text] [Related]
59. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse. Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957 [TBL] [Abstract][Full Text] [Related]
60. Metabolism of amosulalol hydrochloride in man: quantitative comparison with laboratory animals. Kamimura H; Sasaki H; Kawamura S Xenobiotica; 1985 May; 15(5):413-20. PubMed ID: 3929481 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]